Atrás

Butterfly Network, Inc.

Calidad de datos: 100%

BFLY

NYSE Healthcare Medical - Devices

$4.19

▼ $0.05 (-1.18%)

Cap. Mercado: 1.07B

Rango del Día

$4.13 $4.42

Rango de 52 Semanas

$1.32 $5.03

Volumen

5,158,816

Promedio 50D / 200D

$3.82 / $2.65

Cierre Anterior

$4.24

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica	Acción	Mediana del Sector
P/E	-13.8	0.2
P/B	5.4	3.0
ROE %	-42.3	3.6
Net Margin %	-79.0	3.8
Rev Growth 5Y %	11.8	9.9
D/E	0.1	0.2

Precio Objetivo de Analistas

Hold

$5.42 +29.4%

Low: $5.25 High: $5.50

EPS Futuro

-$0.14

Ingresos Est.

116.65M

Estimaciones de Ganancias

Período	EPS Est.	Ingresos Est.	Analistas
FY2030	$0.00 $0.00 – $0.00	220.00M	0
FY2029	$0.00 $0.00 – $0.00	180.00M	0
FY2028	-$0.06 -$0.06 – -$0.06	153.25M	2

Earnings Surprises

Last 8 quarters

Quarter	Est. EPS	Actual EPS	Surprise
2026-02-26	-$0.04	-$0.02	+55.3%
2025-10-31	-$0.07	-$0.13	-85.7%
2025-08-01	-$0.07	-$0.06	+14.3%
2025-05-02	-$0.09	-$0.06	+33.3%
2025-02-28	-$0.09	-$0.08	+11.1%
2024-11-01	-$0.10	-$0.08	+20.0%
2024-08-01	-$0.10	-$0.05	+50.0%
2024-05-01	-$0.12	-$0.07	+41.7%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 11.76% annually over 5 years — strong growth

Debt/Equity of 0.10 — conservative balance sheet

Negative free cash flow of -16.05M

Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.20%

Capital efficient — spends only 3.43% of revenue on capex

Crecimiento

Revenue Growth (5Y)

11.76%

Revenue (1Y)18.96%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Calidad

Return on Equity

-42.25%

ROIC-29.95%

Net Margin-78.95%

Op. Margin-88.53%

Seguridad

Debt / Equity

0.10

Current Ratio3.83

Interest Coverage-58.00

Valoración

P/E Ratio

-13.84

Forward P/EN/A

P/B Ratio5.44

EV/EBITDAN/A

Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	18.96%	Revenue Growth (3Y)	21.70%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	11.76%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	97.61M	Net Income (TTM)	-77.06M
ROE	-42.25%	ROA	-25.99%
Gross Margin	46.85%	Operating Margin	-88.53%
Net Margin	-78.95%	Free Cash Flow (TTM)	-16.05M
ROIC	-29.95%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.10	Current Ratio	3.83
Interest Coverage	-58.00
Dividends
Dividend Yield	0.00%	Payout Ratio	0.00%
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-13.84	Forward P/E	N/A
P/B Ratio	5.44	P/S Ratio	10.93
PEG Ratio	1.38	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	9.15	Fwd Earnings Yield	N/A
FCF Yield	-1.50%
Market Cap	1.07B	Enterprise Value	936.82M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	97.61M	82.06M	65.90M	73.39M	62.57M
Net Income	-77.06M	-72.49M	-133.70M	-168.72M	-32.41M
EPS (Diluted)	-0.31	-0.34	-0.65	-0.84	-0.19
Gross Profit	45.73M	48.83M	16.86M	39.46M	17.05M
Operating Income	-86.42M	-74.41M	-145.61M	-193.02M	-192.73M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	296.53M	256.08M	304.27M	417.57M	571.97M
Total Liabilities	100.55M	87.25M	84.22M	92.21M	124.27M
Shareholders' Equity	195.98M	168.83M	220.05M	325.36M	447.69M
Total Debt	20.40M	22.84M	25.03M	31.89M	29.08M
Cash & Equivalents	150.49M	88.78M	134.64M	162.56M	422.84M
Current Assets	249.10M	192.61M	231.26M	357.14M	511.90M
Current Liabilities	65.12M	48.22M	44.27M	51.33M	49.83M